Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection-Reference-Cited by-同舟云学术

Randomised trial of MNrgp120 HIV-1 vaccine in symptomless HIV-1 infection

Published:1996-12 Issue:9041 Volume:348 Page:1547-1551
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Jr Joseph J Eron,Ashby Mark A,Giordano Michael F,Chernow Marlene,Reiter William M,Deeks Steven G,Lavelle James P,Conant Marcus A,Yangco Bienvenido G,Pate Perry G,Torres Ramón A,Mitsuyasu Ronald T,Twaddell Thomas

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1;Moore;J Virol,1994

2. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome;Koup;J Virol,1994

3. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users;Fernandez;Aids,1990

4. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion;Mellors;Ann Intern Med,1995

5. Risk of developing AIDS after primary acute HIV-1 infection;Sinicco;J Acquir Immune Defic Syndr,1993

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis of HIV-associated pain;HIV-Associated Neurocognitive Disorders;2024

2. IL-31 expression in HIV-infected patients with different routes of disease transmission;Medicine;2022-06-24

3. The HIV Reservoir and Cure and Remission Strategies;Fundamentals of HIV Medicine 2021;2021-06

4. Neuroinflammation in HIV-Related Neuropathic Pain;Frontiers in Pharmacology;2021-04-20

5. Human Immunodeficiency Virus Vaccines;Plotkin's Vaccines;2018